CADENCE PHARMACEUTICALS INC. v. EXELA PHARMSCI

No. 2014-1184.

780 F.3d 1364 (2015)

CADENCE PHARMACEUTICALS INC. SCR Pharmatop, Plaintiffs-Appellees v. EXELA PHARMSCI INC., Exela Holdings Inc., Exela Pharma Sciences LLC, Defendants-Appellants.

United States Court of Appeals, Federal Circuit.

March 23, 2015.


Attorney(s) appearing for the Case

Kenneth G. Schuler , Latham & Watkins LLP, Chicago, IL, argued for all plaintiffs-appellees. Plaintiff-appellee Cadence Pharmaceuticals Inc. also represented by Marc Nathan Zubick , Emily C. Melvin ; Stephen P. Swinton , Darryl Hugh Steensma , San Diego, CA; Richard P. Bress , Gabriel Bell , Washington, DC; Parker Tresemer , Costa Mesa, CA. Plaintiff-appellee SCR Pharmatop represented by Charles A. Weiss , Holland & Knight, LLP, New York, NY.

Jeffrey Stephen Ward , Merchant & Gould PC, Madison, WI, argued for defendants-appellants. Also represented by Wendy M. Ward ; Clarence Edward Polk, Jr. , Polk & Chintapalli, PLLC, Ashburn, VA,; Satish Chandra Chintapalli , Cary, NC.

Before REYNA, LINN, and WALLACH, Circuit Judges.


In this Hatch-Waxman Act litigation, Exela PharmSci Inc., Exela Holdings, Inc. and Exela Pharm Sciences, LLC (collectively "Exela") appeal the district court's construction of certain claim terms of U.S. Patents No. 6,028,222 (the "'222 patent") and No. 6,992,218 (the "'218 patent"), Cadence Pharm., Inc. v. Paddock Labs....

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases